nodes	percent_of_prediction	percent_of_DWPC	metapath
Triazolam—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.105	0.146	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.096	0.135	CbGbCtD
Triazolam—CYP3A7—Progesterone—uterine cancer	0.096	0.135	CbGbCtD
Triazolam—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0729	0.102	CbGbCtD
Triazolam—CYP3A5—Progesterone—uterine cancer	0.072	0.101	CbGbCtD
Triazolam—CYP2C8—Progesterone—uterine cancer	0.0693	0.097	CbGbCtD
Triazolam—CYP2C9—Progesterone—uterine cancer	0.0483	0.0677	CbGbCtD
Triazolam—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0424	0.0594	CbGbCtD
Triazolam—CYP3A5—Etoposide—uterine cancer	0.0322	0.0452	CbGbCtD
Triazolam—CYP2C8—Etoposide—uterine cancer	0.031	0.0434	CbGbCtD
Triazolam—CYP3A4—Progesterone—uterine cancer	0.0281	0.0393	CbGbCtD
Triazolam—CYP3A4—Etoposide—uterine cancer	0.0126	0.0176	CbGbCtD
Triazolam—CYP3A4—Doxorubicin—uterine cancer	0.00857	0.012	CbGbCtD
Triazolam—TSPO—oviduct—uterine cancer	0.00493	0.087	CbGeAlD
Triazolam—TSPO—artery—uterine cancer	0.00327	0.0576	CbGeAlD
Triazolam—TSPO—exocrine gland—uterine cancer	0.00285	0.0502	CbGeAlD
Triazolam—GABRP—uterine cervix—uterine cancer	0.00172	0.0304	CbGeAlD
Triazolam—GABRE—myometrium—uterine cancer	0.00169	0.0298	CbGeAlD
Triazolam—GABRP—decidua—uterine cancer	0.00164	0.029	CbGeAlD
Triazolam—TSPO—myometrium—uterine cancer	0.00158	0.0278	CbGeAlD
Triazolam—GABRP—endometrium—uterine cancer	0.00156	0.0275	CbGeAlD
Triazolam—GABRA4—mammalian vulva—uterine cancer	0.00152	0.0268	CbGeAlD
Triazolam—GABRP—uterus—uterine cancer	0.00144	0.0253	CbGeAlD
Triazolam—GABRE—uterine cervix—uterine cancer	0.00132	0.0232	CbGeAlD
Triazolam—GABRB1—vagina—uterine cancer	0.0013	0.023	CbGeAlD
Triazolam—GABRP—female reproductive system—uterine cancer	0.00129	0.0228	CbGeAlD
Triazolam—GABRE—decidua—uterine cancer	0.00125	0.0221	CbGeAlD
Triazolam—TSPO—epithelium—uterine cancer	0.00124	0.0218	CbGeAlD
Triazolam—TSPO—uterine cervix—uterine cancer	0.00123	0.0217	CbGeAlD
Triazolam—TSPO—smooth muscle tissue—uterine cancer	0.00119	0.021	CbGeAlD
Triazolam—GABRE—endometrium—uterine cancer	0.00119	0.021	CbGeAlD
Triazolam—TSPO—decidua—uterine cancer	0.00117	0.0206	CbGeAlD
Triazolam—GABRP—vagina—uterine cancer	0.00117	0.0206	CbGeAlD
Triazolam—GABRE—mammalian vulva—uterine cancer	0.00115	0.0203	CbGeAlD
Triazolam—TSPO—renal system—uterine cancer	0.00115	0.0203	CbGeAlD
Triazolam—TSPO—endometrium—uterine cancer	0.00111	0.0196	CbGeAlD
Triazolam—GABRR2—lymph node—uterine cancer	0.00108	0.019	CbGeAlD
Triazolam—TSPO—mammalian vulva—uterine cancer	0.00107	0.0189	CbGeAlD
Triazolam—TSPO—uterus—uterine cancer	0.00102	0.0181	CbGeAlD
Triazolam—GABRE—female reproductive system—uterine cancer	0.000986	0.0174	CbGeAlD
Triazolam—Malaise—Progesterone—uterine cancer	0.000981	0.00427	CcSEcCtD
Triazolam—Redness—Doxorubicin—uterine cancer	0.000978	0.00426	CcSEcCtD
Triazolam—Syncope—Progesterone—uterine cancer	0.000975	0.00425	CcSEcCtD
Triazolam—Flatulence—Medroxyprogesterone Acetate—uterine cancer	0.000971	0.00423	CcSEcCtD
Triazolam—Tension—Medroxyprogesterone Acetate—uterine cancer	0.000967	0.00422	CcSEcCtD
Triazolam—Dysgeusia—Medroxyprogesterone Acetate—uterine cancer	0.000965	0.00421	CcSEcCtD
Triazolam—Palpitations—Progesterone—uterine cancer	0.000961	0.00419	CcSEcCtD
Triazolam—Stomatitis—Dactinomycin—uterine cancer	0.000959	0.00418	CcSEcCtD
Triazolam—Nervousness—Medroxyprogesterone Acetate—uterine cancer	0.000957	0.00417	CcSEcCtD
Triazolam—Loss of consciousness—Progesterone—uterine cancer	0.000956	0.00417	CcSEcCtD
Triazolam—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.000947	0.00413	CcSEcCtD
Triazolam—Hypertension—Progesterone—uterine cancer	0.000939	0.00409	CcSEcCtD
Triazolam—Chest pain—Progesterone—uterine cancer	0.000926	0.00404	CcSEcCtD
Triazolam—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.000923	0.00402	CcSEcCtD
Triazolam—Anxiety—Progesterone—uterine cancer	0.000923	0.00402	CcSEcCtD
Triazolam—TSPO—female reproductive system—uterine cancer	0.000921	0.0162	CbGeAlD
Triazolam—Discomfort—Progesterone—uterine cancer	0.000915	0.00399	CcSEcCtD
Triazolam—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.000914	0.00399	CcSEcCtD
Triazolam—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.000906	0.00395	CcSEcCtD
Triazolam—Dry mouth—Progesterone—uterine cancer	0.000905	0.00395	CcSEcCtD
Triazolam—GABRA2—vagina—uterine cancer	0.000899	0.0159	CbGeAlD
Triazolam—GABRE—female gonad—uterine cancer	0.000897	0.0158	CbGeAlD
Triazolam—Confusional state—Progesterone—uterine cancer	0.000895	0.0039	CcSEcCtD
Triazolam—GABRE—vagina—uterine cancer	0.000892	0.0157	CbGeAlD
Triazolam—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.000889	0.00387	CcSEcCtD
Triazolam—Oedema—Progesterone—uterine cancer	0.000888	0.00387	CcSEcCtD
Triazolam—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.000884	0.00385	CcSEcCtD
Triazolam—Shock—Progesterone—uterine cancer	0.000873	0.00381	CcSEcCtD
Triazolam—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.000871	0.0038	CcSEcCtD
Triazolam—Tachycardia—Progesterone—uterine cancer	0.000866	0.00378	CcSEcCtD
Triazolam—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.000866	0.00378	CcSEcCtD
Triazolam—Hyperhidrosis—Progesterone—uterine cancer	0.000858	0.00374	CcSEcCtD
Triazolam—Anorexia—Progesterone—uterine cancer	0.000846	0.00369	CcSEcCtD
Triazolam—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.000839	0.00366	CcSEcCtD
Triazolam—TSPO—female gonad—uterine cancer	0.000838	0.0148	CbGeAlD
Triazolam—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.000836	0.00364	CcSEcCtD
Triazolam—GABRB3—female reproductive system—uterine cancer	0.000836	0.0147	CbGeAlD
Triazolam—TSPO—vagina—uterine cancer	0.000833	0.0147	CbGeAlD
Triazolam—Cramp muscle—Etoposide—uterine cancer	0.000832	0.00363	CcSEcCtD
Triazolam—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000829	0.00361	CcSEcCtD
Triazolam—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.00082	0.00358	CcSEcCtD
Triazolam—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.000811	0.00353	CcSEcCtD
Triazolam—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.000804	0.00351	CcSEcCtD
Triazolam—Insomnia—Progesterone—uterine cancer	0.000803	0.0035	CcSEcCtD
Triazolam—Paraesthesia—Progesterone—uterine cancer	0.000797	0.00347	CcSEcCtD
Triazolam—Dyspnoea—Progesterone—uterine cancer	0.000791	0.00345	CcSEcCtD
Triazolam—Shock—Medroxyprogesterone Acetate—uterine cancer	0.000791	0.00345	CcSEcCtD
Triazolam—Somnolence—Progesterone—uterine cancer	0.000789	0.00344	CcSEcCtD
Triazolam—CYP2C8—renal system—uterine cancer	0.000789	0.0139	CbGeAlD
Triazolam—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.000785	0.00342	CcSEcCtD
Triazolam—Thinking abnormal—Epirubicin—uterine cancer	0.000779	0.0034	CcSEcCtD
Triazolam—Sweating increased—Etoposide—uterine cancer	0.000778	0.00339	CcSEcCtD
Triazolam—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.000777	0.00339	CcSEcCtD
Triazolam—Glossitis—Epirubicin—uterine cancer	0.000774	0.00337	CcSEcCtD
Triazolam—Decreased appetite—Progesterone—uterine cancer	0.000772	0.00336	CcSEcCtD
Triazolam—Erythema—Dactinomycin—uterine cancer	0.000769	0.00335	CcSEcCtD
Triazolam—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000767	0.00334	CcSEcCtD
Triazolam—Fatigue—Progesterone—uterine cancer	0.000765	0.00334	CcSEcCtD
Triazolam—CYP2C8—endometrium—uterine cancer	0.000763	0.0134	CbGeAlD
Triazolam—CYP3A5—uterine cervix—uterine cancer	0.000761	0.0134	CbGeAlD
Triazolam—Pain—Progesterone—uterine cancer	0.000759	0.00331	CcSEcCtD
Triazolam—Constipation—Progesterone—uterine cancer	0.000759	0.00331	CcSEcCtD
Triazolam—Dysarthria—Epirubicin—uterine cancer	0.000754	0.00329	CcSEcCtD
Triazolam—Feeling abnormal—Progesterone—uterine cancer	0.000731	0.00319	CcSEcCtD
Triazolam—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000727	0.00317	CcSEcCtD
Triazolam—Coordination abnormal—Epirubicin—uterine cancer	0.000726	0.00317	CcSEcCtD
Triazolam—Gastrointestinal pain—Progesterone—uterine cancer	0.000726	0.00316	CcSEcCtD
Triazolam—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000722	0.00315	CcSEcCtD
Triazolam—Thinking abnormal—Doxorubicin—uterine cancer	0.000721	0.00314	CcSEcCtD
Triazolam—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000717	0.00313	CcSEcCtD
Triazolam—Glossitis—Doxorubicin—uterine cancer	0.000716	0.00312	CcSEcCtD
Triazolam—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000715	0.00312	CcSEcCtD
Triazolam—Ill-defined disorder—Dactinomycin—uterine cancer	0.000713	0.00311	CcSEcCtD
Triazolam—CYP3A5—renal system—uterine cancer	0.000712	0.0125	CbGeAlD
Triazolam—Abdominal pain—Progesterone—uterine cancer	0.000702	0.00306	CcSEcCtD
Triazolam—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000699	0.00305	CcSEcCtD
Triazolam—Dysarthria—Doxorubicin—uterine cancer	0.000698	0.00304	CcSEcCtD
Triazolam—Jaundice—Etoposide—uterine cancer	0.000694	0.00302	CcSEcCtD
Triazolam—Stomatitis—Etoposide—uterine cancer	0.000694	0.00302	CcSEcCtD
Triazolam—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000693	0.00302	CcSEcCtD
Triazolam—Malaise—Dactinomycin—uterine cancer	0.000693	0.00302	CcSEcCtD
Triazolam—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000688	0.003	CcSEcCtD
Triazolam—Coordination abnormal—Doxorubicin—uterine cancer	0.000672	0.00293	CcSEcCtD
Triazolam—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000663	0.00289	CcSEcCtD
Triazolam—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000658	0.00287	CcSEcCtD
Triazolam—Hypersensitivity—Progesterone—uterine cancer	0.000654	0.00285	CcSEcCtD
Triazolam—Discomfort—Dactinomycin—uterine cancer	0.000647	0.00282	CcSEcCtD
Triazolam—Asthenia—Progesterone—uterine cancer	0.000637	0.00278	CcSEcCtD
Triazolam—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000636	0.00277	CcSEcCtD
Triazolam—CYP2C8—female reproductive system—uterine cancer	0.000632	0.0111	CbGeAlD
Triazolam—Pruritus—Progesterone—uterine cancer	0.000628	0.00274	CcSEcCtD
Triazolam—Oedema—Dactinomycin—uterine cancer	0.000627	0.00273	CcSEcCtD
Triazolam—Mental disability—Epirubicin—uterine cancer	0.000619	0.0027	CcSEcCtD
Triazolam—Diarrhoea—Progesterone—uterine cancer	0.000607	0.00265	CcSEcCtD
Triazolam—Anorexia—Dactinomycin—uterine cancer	0.000598	0.00261	CcSEcCtD
Triazolam—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000593	0.00258	CcSEcCtD
Triazolam—Dizziness—Progesterone—uterine cancer	0.000587	0.00256	CcSEcCtD
Triazolam—GABRA2—lymph node—uterine cancer	0.000582	0.0103	CbGeAlD
Triazolam—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000577	0.00252	CcSEcCtD
Triazolam—GABRE—lymph node—uterine cancer	0.000577	0.0102	CbGeAlD
Triazolam—Hepatic failure—Epirubicin—uterine cancer	0.000576	0.00251	CcSEcCtD
Triazolam—Mental disability—Doxorubicin—uterine cancer	0.000573	0.0025	CcSEcCtD
Triazolam—CYP2C8—vagina—uterine cancer	0.000571	0.0101	CbGeAlD
Triazolam—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000569	0.00248	CcSEcCtD
Triazolam—Vomiting—Progesterone—uterine cancer	0.000564	0.00246	CcSEcCtD
Triazolam—CYP2C9—female reproductive system—uterine cancer	0.000561	0.00989	CbGeAlD
Triazolam—Dermatitis—Progesterone—uterine cancer	0.000559	0.00244	CcSEcCtD
Triazolam—Headache—Progesterone—uterine cancer	0.000556	0.00242	CcSEcCtD
Triazolam—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00055	0.0024	CcSEcCtD
Triazolam—Decreased appetite—Dactinomycin—uterine cancer	0.000545	0.00238	CcSEcCtD
Triazolam—Dysgeusia—Etoposide—uterine cancer	0.000545	0.00237	CcSEcCtD
Triazolam—Fatigue—Dactinomycin—uterine cancer	0.000541	0.00236	CcSEcCtD
Triazolam—TSPO—lymph node—uterine cancer	0.000539	0.00949	CbGeAlD
Triazolam—Pain—Dactinomycin—uterine cancer	0.000536	0.00234	CcSEcCtD
Triazolam—Muscle spasms—Etoposide—uterine cancer	0.000535	0.00233	CcSEcCtD
Triazolam—CYP3A4—renal system—uterine cancer	0.000534	0.00942	CbGeAlD
Triazolam—Hepatic failure—Doxorubicin—uterine cancer	0.000533	0.00232	CcSEcCtD
Triazolam—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000532	0.00232	CcSEcCtD
Triazolam—Nausea—Progesterone—uterine cancer	0.000527	0.0023	CcSEcCtD
Triazolam—CYP3A5—female gonad—uterine cancer	0.000519	0.00915	CbGeAlD
Triazolam—Osteoarthritis—Epirubicin—uterine cancer	0.000518	0.00226	CcSEcCtD
Triazolam—Feeling abnormal—Dactinomycin—uterine cancer	0.000517	0.00225	CcSEcCtD
Triazolam—Ill-defined disorder—Etoposide—uterine cancer	0.000516	0.00225	CcSEcCtD
Triazolam—CYP3A5—vagina—uterine cancer	0.000516	0.00909	CbGeAlD
Triazolam—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000513	0.00224	CcSEcCtD
Triazolam—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000511	0.00223	CcSEcCtD
Triazolam—Affect lability—Epirubicin—uterine cancer	0.00051	0.00222	CcSEcCtD
Triazolam—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000507	0.00221	CcSEcCtD
Triazolam—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000504	0.0022	CcSEcCtD
Triazolam—Malaise—Etoposide—uterine cancer	0.000502	0.00219	CcSEcCtD
Triazolam—Abdominal pain—Dactinomycin—uterine cancer	0.000496	0.00216	CcSEcCtD
Triazolam—Mood swings—Epirubicin—uterine cancer	0.000491	0.00214	CcSEcCtD
Triazolam—Loss of consciousness—Etoposide—uterine cancer	0.000489	0.00213	CcSEcCtD
Triazolam—Ataxia—Epirubicin—uterine cancer	0.000487	0.00212	CcSEcCtD
Triazolam—Hypertension—Etoposide—uterine cancer	0.00048	0.00209	CcSEcCtD
Triazolam—Osteoarthritis—Doxorubicin—uterine cancer	0.000479	0.00209	CcSEcCtD
Triazolam—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000478	0.00208	CcSEcCtD
Triazolam—Chest pain—Etoposide—uterine cancer	0.000474	0.00206	CcSEcCtD
Triazolam—Affect lability—Doxorubicin—uterine cancer	0.000472	0.00206	CcSEcCtD
Triazolam—Discomfort—Etoposide—uterine cancer	0.000468	0.00204	CcSEcCtD
Triazolam—Hypersensitivity—Dactinomycin—uterine cancer	0.000462	0.00201	CcSEcCtD
Triazolam—Confusional state—Etoposide—uterine cancer	0.000458	0.002	CcSEcCtD
Triazolam—Muscular weakness—Epirubicin—uterine cancer	0.000457	0.00199	CcSEcCtD
Triazolam—Mood swings—Doxorubicin—uterine cancer	0.000454	0.00198	CcSEcCtD
Triazolam—Ataxia—Doxorubicin—uterine cancer	0.000451	0.00196	CcSEcCtD
Triazolam—Asthenia—Dactinomycin—uterine cancer	0.00045	0.00196	CcSEcCtD
Triazolam—Tachycardia—Etoposide—uterine cancer	0.000443	0.00193	CcSEcCtD
Triazolam—Hyperhidrosis—Etoposide—uterine cancer	0.000439	0.00191	CcSEcCtD
Triazolam—Anorexia—Etoposide—uterine cancer	0.000433	0.00189	CcSEcCtD
Triazolam—Diarrhoea—Dactinomycin—uterine cancer	0.000429	0.00187	CcSEcCtD
Triazolam—CYP3A4—female reproductive system—uterine cancer	0.000428	0.00754	CbGeAlD
Triazolam—Muscular weakness—Doxorubicin—uterine cancer	0.000423	0.00184	CcSEcCtD
Triazolam—Dysuria—Epirubicin—uterine cancer	0.000418	0.00182	CcSEcCtD
Triazolam—Paraesthesia—Etoposide—uterine cancer	0.000408	0.00178	CcSEcCtD
Triazolam—Dyspnoea—Etoposide—uterine cancer	0.000405	0.00176	CcSEcCtD
Triazolam—Somnolence—Etoposide—uterine cancer	0.000404	0.00176	CcSEcCtD
Triazolam—Drowsiness—Epirubicin—uterine cancer	0.000399	0.00174	CcSEcCtD
Triazolam—Vomiting—Dactinomycin—uterine cancer	0.000399	0.00174	CcSEcCtD
Triazolam—Decreased appetite—Etoposide—uterine cancer	0.000395	0.00172	CcSEcCtD
Triazolam—Fatigue—Etoposide—uterine cancer	0.000391	0.00171	CcSEcCtD
Triazolam—Stomatitis—Epirubicin—uterine cancer	0.000389	0.0017	CcSEcCtD
Triazolam—Jaundice—Epirubicin—uterine cancer	0.000389	0.0017	CcSEcCtD
Triazolam—Pain—Etoposide—uterine cancer	0.000388	0.00169	CcSEcCtD
Triazolam—Constipation—Etoposide—uterine cancer	0.000388	0.00169	CcSEcCtD
Triazolam—Dysuria—Doxorubicin—uterine cancer	0.000387	0.00169	CcSEcCtD
Triazolam—Feeling abnormal—Etoposide—uterine cancer	0.000374	0.00163	CcSEcCtD
Triazolam—Nausea—Dactinomycin—uterine cancer	0.000373	0.00162	CcSEcCtD
Triazolam—Gastrointestinal pain—Etoposide—uterine cancer	0.000371	0.00162	CcSEcCtD
Triazolam—Drowsiness—Doxorubicin—uterine cancer	0.000369	0.00161	CcSEcCtD
Triazolam—Stomatitis—Doxorubicin—uterine cancer	0.00036	0.00157	CcSEcCtD
Triazolam—Jaundice—Doxorubicin—uterine cancer	0.00036	0.00157	CcSEcCtD
Triazolam—Abdominal pain—Etoposide—uterine cancer	0.000359	0.00156	CcSEcCtD
Triazolam—Visual impairment—Epirubicin—uterine cancer	0.000345	0.0015	CcSEcCtD
Triazolam—Hypersensitivity—Etoposide—uterine cancer	0.000335	0.00146	CcSEcCtD
Triazolam—Tinnitus—Epirubicin—uterine cancer	0.000334	0.00146	CcSEcCtD
Triazolam—Asthenia—Etoposide—uterine cancer	0.000326	0.00142	CcSEcCtD
Triazolam—Pruritus—Etoposide—uterine cancer	0.000321	0.0014	CcSEcCtD
Triazolam—Visual impairment—Doxorubicin—uterine cancer	0.000319	0.00139	CcSEcCtD
Triazolam—Erythema—Epirubicin—uterine cancer	0.000312	0.00136	CcSEcCtD
Triazolam—Diarrhoea—Etoposide—uterine cancer	0.000311	0.00135	CcSEcCtD
Triazolam—Tinnitus—Doxorubicin—uterine cancer	0.000309	0.00135	CcSEcCtD
Triazolam—Flatulence—Epirubicin—uterine cancer	0.000307	0.00134	CcSEcCtD
Triazolam—Tension—Epirubicin—uterine cancer	0.000306	0.00133	CcSEcCtD
Triazolam—Dysgeusia—Epirubicin—uterine cancer	0.000305	0.00133	CcSEcCtD
Triazolam—Nervousness—Epirubicin—uterine cancer	0.000303	0.00132	CcSEcCtD
Triazolam—Dizziness—Etoposide—uterine cancer	0.0003	0.00131	CcSEcCtD
Triazolam—Muscle spasms—Epirubicin—uterine cancer	0.0003	0.00131	CcSEcCtD
Triazolam—Ill-defined disorder—Epirubicin—uterine cancer	0.000289	0.00126	CcSEcCtD
Triazolam—Vomiting—Etoposide—uterine cancer	0.000289	0.00126	CcSEcCtD
Triazolam—Erythema—Doxorubicin—uterine cancer	0.000289	0.00126	CcSEcCtD
Triazolam—Agitation—Epirubicin—uterine cancer	0.000287	0.00125	CcSEcCtD
Triazolam—Dermatitis—Etoposide—uterine cancer	0.000286	0.00125	CcSEcCtD
Triazolam—Headache—Etoposide—uterine cancer	0.000284	0.00124	CcSEcCtD
Triazolam—Flatulence—Doxorubicin—uterine cancer	0.000284	0.00124	CcSEcCtD
Triazolam—Tension—Doxorubicin—uterine cancer	0.000283	0.00123	CcSEcCtD
Triazolam—Dysgeusia—Doxorubicin—uterine cancer	0.000283	0.00123	CcSEcCtD
Triazolam—Malaise—Epirubicin—uterine cancer	0.000281	0.00123	CcSEcCtD
Triazolam—Nervousness—Doxorubicin—uterine cancer	0.00028	0.00122	CcSEcCtD
Triazolam—Syncope—Epirubicin—uterine cancer	0.00028	0.00122	CcSEcCtD
Triazolam—Muscle spasms—Doxorubicin—uterine cancer	0.000277	0.00121	CcSEcCtD
Triazolam—Palpitations—Epirubicin—uterine cancer	0.000276	0.0012	CcSEcCtD
Triazolam—Loss of consciousness—Epirubicin—uterine cancer	0.000274	0.00119	CcSEcCtD
Triazolam—Nausea—Etoposide—uterine cancer	0.00027	0.00118	CcSEcCtD
Triazolam—Hypertension—Epirubicin—uterine cancer	0.000269	0.00117	CcSEcCtD
Triazolam—Ill-defined disorder—Doxorubicin—uterine cancer	0.000268	0.00117	CcSEcCtD
Triazolam—Chest pain—Epirubicin—uterine cancer	0.000265	0.00116	CcSEcCtD
Triazolam—Agitation—Doxorubicin—uterine cancer	0.000265	0.00116	CcSEcCtD
Triazolam—Anxiety—Epirubicin—uterine cancer	0.000265	0.00115	CcSEcCtD
Triazolam—Discomfort—Epirubicin—uterine cancer	0.000262	0.00114	CcSEcCtD
Triazolam—Malaise—Doxorubicin—uterine cancer	0.00026	0.00113	CcSEcCtD
Triazolam—Dry mouth—Epirubicin—uterine cancer	0.00026	0.00113	CcSEcCtD
Triazolam—Syncope—Doxorubicin—uterine cancer	0.000259	0.00113	CcSEcCtD
Triazolam—Confusional state—Epirubicin—uterine cancer	0.000257	0.00112	CcSEcCtD
Triazolam—Palpitations—Doxorubicin—uterine cancer	0.000255	0.00111	CcSEcCtD
Triazolam—Oedema—Epirubicin—uterine cancer	0.000255	0.00111	CcSEcCtD
Triazolam—Loss of consciousness—Doxorubicin—uterine cancer	0.000254	0.00111	CcSEcCtD
Triazolam—Shock—Epirubicin—uterine cancer	0.00025	0.00109	CcSEcCtD
Triazolam—Hypertension—Doxorubicin—uterine cancer	0.000249	0.00109	CcSEcCtD
Triazolam—Tachycardia—Epirubicin—uterine cancer	0.000248	0.00108	CcSEcCtD
Triazolam—Hyperhidrosis—Epirubicin—uterine cancer	0.000246	0.00107	CcSEcCtD
Triazolam—Chest pain—Doxorubicin—uterine cancer	0.000246	0.00107	CcSEcCtD
Triazolam—Anxiety—Doxorubicin—uterine cancer	0.000245	0.00107	CcSEcCtD
Triazolam—Discomfort—Doxorubicin—uterine cancer	0.000243	0.00106	CcSEcCtD
Triazolam—Anorexia—Epirubicin—uterine cancer	0.000243	0.00106	CcSEcCtD
Triazolam—Dry mouth—Doxorubicin—uterine cancer	0.00024	0.00105	CcSEcCtD
Triazolam—Confusional state—Doxorubicin—uterine cancer	0.000237	0.00104	CcSEcCtD
Triazolam—Oedema—Doxorubicin—uterine cancer	0.000235	0.00103	CcSEcCtD
Triazolam—Shock—Doxorubicin—uterine cancer	0.000232	0.00101	CcSEcCtD
Triazolam—Insomnia—Epirubicin—uterine cancer	0.00023	0.001	CcSEcCtD
Triazolam—Tachycardia—Doxorubicin—uterine cancer	0.00023	0.001	CcSEcCtD
Triazolam—Paraesthesia—Epirubicin—uterine cancer	0.000229	0.000996	CcSEcCtD
Triazolam—Hyperhidrosis—Doxorubicin—uterine cancer	0.000228	0.000992	CcSEcCtD
Triazolam—Dyspnoea—Epirubicin—uterine cancer	0.000227	0.000989	CcSEcCtD
Triazolam—Somnolence—Epirubicin—uterine cancer	0.000226	0.000986	CcSEcCtD
Triazolam—Anorexia—Doxorubicin—uterine cancer	0.000224	0.000978	CcSEcCtD
Triazolam—Decreased appetite—Epirubicin—uterine cancer	0.000221	0.000964	CcSEcCtD
Triazolam—Fatigue—Epirubicin—uterine cancer	0.000219	0.000956	CcSEcCtD
Triazolam—Constipation—Epirubicin—uterine cancer	0.000218	0.000949	CcSEcCtD
Triazolam—Pain—Epirubicin—uterine cancer	0.000218	0.000949	CcSEcCtD
Triazolam—Insomnia—Doxorubicin—uterine cancer	0.000213	0.000928	CcSEcCtD
Triazolam—Paraesthesia—Doxorubicin—uterine cancer	0.000211	0.000922	CcSEcCtD
Triazolam—Dyspnoea—Doxorubicin—uterine cancer	0.00021	0.000915	CcSEcCtD
Triazolam—Feeling abnormal—Epirubicin—uterine cancer	0.00021	0.000914	CcSEcCtD
Triazolam—Somnolence—Doxorubicin—uterine cancer	0.000209	0.000913	CcSEcCtD
Triazolam—Gastrointestinal pain—Epirubicin—uterine cancer	0.000208	0.000907	CcSEcCtD
Triazolam—Decreased appetite—Doxorubicin—uterine cancer	0.000205	0.000892	CcSEcCtD
Triazolam—Fatigue—Doxorubicin—uterine cancer	0.000203	0.000885	CcSEcCtD
Triazolam—Constipation—Doxorubicin—uterine cancer	0.000201	0.000878	CcSEcCtD
Triazolam—Pain—Doxorubicin—uterine cancer	0.000201	0.000878	CcSEcCtD
Triazolam—Abdominal pain—Epirubicin—uterine cancer	0.000201	0.000877	CcSEcCtD
Triazolam—Feeling abnormal—Doxorubicin—uterine cancer	0.000194	0.000846	CcSEcCtD
Triazolam—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000193	0.000839	CcSEcCtD
Triazolam—Hypersensitivity—Epirubicin—uterine cancer	0.000188	0.000817	CcSEcCtD
Triazolam—Abdominal pain—Doxorubicin—uterine cancer	0.000186	0.000811	CcSEcCtD
Triazolam—Asthenia—Epirubicin—uterine cancer	0.000183	0.000796	CcSEcCtD
Triazolam—Pruritus—Epirubicin—uterine cancer	0.00018	0.000785	CcSEcCtD
Triazolam—Diarrhoea—Epirubicin—uterine cancer	0.000174	0.000759	CcSEcCtD
Triazolam—Hypersensitivity—Doxorubicin—uterine cancer	0.000173	0.000756	CcSEcCtD
Triazolam—Asthenia—Doxorubicin—uterine cancer	0.000169	0.000736	CcSEcCtD
Triazolam—Dizziness—Epirubicin—uterine cancer	0.000168	0.000734	CcSEcCtD
Triazolam—Pruritus—Doxorubicin—uterine cancer	0.000167	0.000726	CcSEcCtD
Triazolam—Vomiting—Epirubicin—uterine cancer	0.000162	0.000705	CcSEcCtD
Triazolam—Diarrhoea—Doxorubicin—uterine cancer	0.000161	0.000702	CcSEcCtD
Triazolam—Dermatitis—Epirubicin—uterine cancer	0.00016	0.000699	CcSEcCtD
Triazolam—Headache—Epirubicin—uterine cancer	0.000159	0.000695	CcSEcCtD
Triazolam—Dizziness—Doxorubicin—uterine cancer	0.000156	0.000679	CcSEcCtD
Triazolam—Nausea—Epirubicin—uterine cancer	0.000151	0.000659	CcSEcCtD
Triazolam—Vomiting—Doxorubicin—uterine cancer	0.00015	0.000653	CcSEcCtD
Triazolam—Dermatitis—Doxorubicin—uterine cancer	0.000148	0.000647	CcSEcCtD
Triazolam—Headache—Doxorubicin—uterine cancer	0.000148	0.000643	CcSEcCtD
Triazolam—Nausea—Doxorubicin—uterine cancer	0.00014	0.00061	CcSEcCtD
